An overview of the analysis of additional features
| Total 98 patients | RDR | No RDR | p Value |
|---|---|---|---|
| Age (median [IQR]) | 75.2 [71.4–79.3] | 72.0 [66.6–75.8] | 0.018 |
| Gender | Female: 36 | Female: 32 | 0.006 |
| Male: 7 | Male: 23 | ||
| AREDS stage | 3: 10 | 3: 13 | 0.965 |
| 4: 33 | 4: 42 | ||
| Conversion rate into late AMD | All: 7 | All: 12 | 0.601 |
| CNV: 3 | CNV: 7 | 0.515 | |
| GA: 4 | GA: 5 | 0.515 | |
| Diagnosis of the fellow eye | Early: 0 | Early: 1 | 0.305 |
| Intermediate: 10 | Intermediate: 12 | ||
| GA: 4 | GA: 1 | ||
| CNV: 29 | CNV: 41 |
Age, gender, AREDS stage, conversion rate into late AMD and the diagnosis of the fellow eyes are compared between patients with and without RDR.
AMD, age-related macular degeneration; AREDS, age-related eye disease study; CNV, choroidal neovascularisation; GA, geographic atrophy; RDR, reticular drusen.